Myths and facts about diet in metabolic dysfunction-associated steatotic liver disease—part II: Nutrition during incretin-based therapy
World Journal of Gastrointestinal Pharmacology and Therapeutics · 09.11.2026
DOI: 10.4292/wjgpt.128040 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastrointestinal Pharmacology and Therapeutics, online erschienen am 09.11.2026. Verfasst von Sabrina Alves Fernandes und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Fernandes, S. A., & Araujo-Neto, J. M. (2026). Myths and facts about diet in metabolic dysfunction-associated steatotic liver disease—part II: Nutrition during incretin-based therapy. World Journal of Gastrointestinal Pharmacology and Therapeutics. https://doi.org/10.4292/wjgpt.128040
Vancouver
Fernandes SA, Araujo-Neto JM. Myths and facts about diet in metabolic dysfunction-associated steatotic liver disease—part II: Nutrition during incretin-based therapy. World Journal of Gastrointestinal Pharmacology and Therapeutics. 2026. doi:10.4292/wjgpt.128040
BibTeX
@article{Fernandes2026,
author = {Fernandes, Sabrina Alves and Araujo-Neto, João Marcello},
title = {Myths and facts about diet in metabolic dysfunction-associated steatotic liver disease—part II: Nutrition during incretin-based therapy},
journal = {World Journal of Gastrointestinal Pharmacology and Therapeutics},
year = {2026},
doi = {10.4292/wjgpt.128040}
}
EUVIMED